Dare Bioscience, Inc. Deferred Tax Assets, Tax Deferred Expense
Dare Bioscience, Inc. (DARE) had Deferred Tax Assets, Tax Deferred Expense of $4.45 million as of 2016-12-31, per its 10-K/A filed 2017-06-13.
Discontinued › Notes › Income Taxes
us-gaap:DeferredTaxAssetsTaxDeferredExpense · last filed 2017-06-13
- 2016-12-31: Deferred Tax Assets, Tax Deferred Expense $4.45M; Deferred Tax Assets, Tax Deferred Expense as first filed $4.45K.
- 2015-12-31: Deferred Tax Assets, Tax Deferred Expense $3.98M; Deferred Tax Assets, Tax Deferred Expense as first filed $3.98K.
- 2015-12-15: Deferred Tax Assets, Tax Deferred Expense $3.98K.
- 2014-12-31: Deferred Tax Assets, Tax Deferred Expense $3.50K.
| Period end | Deferred Tax Assets, Tax Deferred Expense | Deferred Tax Assets, Tax Deferred Expense as first filed |
|---|---|---|
| 2016-12-31 | $4.45M 10-K/A · filed 2017-06-13 | $4.45K 10-K · filed 2017-03-31 |
| 2015-12-31 | $3.98M 10-K/A · filed 2017-06-13 | $3.98K 10-K · filed 2017-03-31 |
| 2015-12-15 | $3.98K 10-K · filed 2016-03-10 | |
| 2014-12-31 | $3.50K 10-K · filed 2016-03-10 | |
| 2013-12-31 | $3.07K 10-K · filed 2015-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |